Prognostic Association of Prostate-specific Antigen Decline with Clinical Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Treated with Enzalutamide in a Randomized Clinical Trial

Authors:

Abstract
No abstract available
Funding Information
  • Boehringer Ingelheim
  • Novartis
  • Astellas Pharma
  • AbbVie
  • Canada Millennium Scholarship Foundation
  • Pfizer
  • Janssen Research and Development
  • Sanofi
  • Bristol-Myers Squibb
  • Eisai
  • Pfizer
  • Phycological Society of America
  • Bayer
  • Johnson & Johnson Innovative Medicine
  • European Society for Medical Oncology
  • Sanofi
  • Johnson & Johnson Innovative Medicine
  • Genentech
  • Gilead Sciences
  • AstraZeneca
  • Astellas Pharma
  • Amgen

This publication has 19 references indexed in Scilit: